Joussen AM - Search Results

1

Sustained inhibition of corneal neovascularization by genetic ablation of CCR5.

Ambati BK, Anand A, Joussen AM, Kuziel WA, Adamis AP, Ambati J. Ambati BK, et al. Among authors: joussen am. Invest Ophthalmol Vis Sci. 2003 Feb;44(2):590-3. doi: 10.1167/iovs.02-0685. Invest Ophthalmol Vis Sci. 2003. PMID: 12556387

2

In vivo fluorescence microscopy of corneal neovascularization.

Becker MD, Kruse FE, Joussen AM, Rohrschneider K, Nobiling R, Gebhard MM, Völcker HE. Becker MD, et al. Among authors: joussen am. Graefes Arch Clin Exp Ophthalmol. 1998 May;236(5):390-8. doi: 10.1007/s004170050095. Graefes Arch Clin Exp Ophthalmol. 1998. PMID: 9602324

3

CD18 and ICAM-1-dependent corneal neovascularization and inflammation after limbal injury.

Moromizato Y, Stechschulte S, Miyamoto K, Murata T, Tsujikawa A, Joussen AM, Adamis AP. Moromizato Y, et al. Among authors: joussen am. Am J Pathol. 2000 Oct;157(4):1277-81. doi: 10.1016/S0002-9440(10)64643-3. Am J Pathol. 2000. PMID: 11021832 Free PMC article.

4

Leukocyte-mediated endothelial cell injury and death in the diabetic retina.

Joussen AM, Murata T, Tsujikawa A, Kirchhof B, Bursell SE, Adamis AP. Joussen AM, et al. Am J Pathol. 2001 Jan;158(1):147-52. doi: 10.1016/S0002-9440(10)63952-1. Am J Pathol. 2001. PMID: 11141487 Free PMC article.

5

Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium.

Schwesinger C, Yee C, Rohan RM, Joussen AM, Fernandez A, Meyer TN, Poulaki V, Ma JJ, Redmond TM, Liu S, Adamis AP, D'Amato RJ. Schwesinger C, et al. Among authors: joussen am. Am J Pathol. 2001 Mar;158(3):1161-72. doi: 10.1016/S0002-9440(10)64063-1. Am J Pathol. 2001. PMID: 11238064 Free PMC article.

6

Rapid ocular angiogenic control via naked DNA delivery to cornea.

Stechschulte SU, Joussen AM, von Recum HA, Poulaki V, Moromizato Y, Yuan J, D'Amato RJ, Kuo C, Adamis AP. Stechschulte SU, et al. Among authors: joussen am. Invest Ophthalmol Vis Sci. 2001 Aug;42(9):1975-9. Invest Ophthalmol Vis Sci. 2001. PMID: 11481260

7

VEGF-initiated blood-retinal barrier breakdown in early diabetes.

Qaum T, Xu Q, Joussen AM, Clemens MW, Qin W, Miyamoto K, Hassessian H, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis AP. Qaum T, et al. Among authors: joussen am. Invest Ophthalmol Vis Sci. 2001 Sep;42(10):2408-13. Invest Ophthalmol Vis Sci. 2001. PMID: 11527957

8

Inhibition of inflammatory corneal angiogenesis by TNP-470.

Joussen AM, Beecken WD, Moromizato Y, Schwartz A, Kirchhof B, Poulaki V. Joussen AM, et al. Invest Ophthalmol Vis Sci. 2001 Oct;42(11):2510-6. Invest Ophthalmol Vis Sci. 2001. PMID: 11581191

9

In vivo retinal gene expression in early diabetes.

Joussen AM, Huang S, Poulaki V, Camphausen K, Beecken WD, Kirchhof B, Adamis AP. Joussen AM, et al. Invest Ophthalmol Vis Sci. 2001 Nov;42(12):3047-57. Invest Ophthalmol Vis Sci. 2001. PMID: 11687554

10

Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression.

Joussen AM, Poulaki V, Mitsiades N, Kirchhof B, Koizumi K, Döhmen S, Adamis AP. Joussen AM, et al. FASEB J. 2002 Mar;16(3):438-40. doi: 10.1096/fj.01-0707fje. Epub 2002 Jan 30. FASEB J. 2002. PMID: 11821258

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

326 results

Search Page

Filters